[
  {
    "title": "Charles River (CRL) Q1 Earnings on the Horizon: Analysts' Insights on Key Performance Measures",
    "published": 1715001357,
    "day_prices": {
      "2024-05-06T13:30:00+00:00": 235.60000610351562,
      "2024-05-06T14:30:00+00:00": 235.08999633789062,
      "2024-05-06T15:30:00+00:00": 233.75,
      "2024-05-06T16:30:00+00:00": 234.58999633789062,
      "2024-05-06T17:30:00+00:00": 234.72000122070312,
      "2024-05-06T18:30:00+00:00": 235.32000732421875,
      "2024-05-06T19:30:00+00:00": 234.25999450683594
    },
    "sentiment": 0.7930102348327637
  },
  {
    "title": "Sotera Health Company (SHC) Misses Q1 Earnings and Revenue Estimates",
    "published": 1714653305,
    "day_prices": {
      "2024-05-02T13:30:00+00:00": 233.85000610351562,
      "2024-05-02T14:30:00+00:00": 229.02000427246094,
      "2024-05-02T15:30:00+00:00": 230.3699951171875,
      "2024-05-02T16:30:00+00:00": 228.94000244140625,
      "2024-05-02T17:30:00+00:00": 229.9199981689453,
      "2024-05-02T18:30:00+00:00": 230.11500549316406,
      "2024-05-02T19:30:00+00:00": 230.58999633789062
    },
    "sentiment": 0.9690886735916138
  },
  {
    "title": "Analysts Offer Insights on Healthcare Companies: Stryker (SYK), Charles River Labs (CRL) and Neurocrine (NBIX)",
    "published": 1714548000,
    "day_prices": {
      "2024-05-01T13:30:00+00:00": 229.8000030517578,
      "2024-05-01T14:30:00+00:00": 226.88999938964844,
      "2024-05-01T15:30:00+00:00": 228.02999877929688,
      "2024-05-01T16:30:00+00:00": 229.47000122070312,
      "2024-05-01T17:30:00+00:00": 229.47999572753906,
      "2024-05-01T18:30:00+00:00": 231.32000732421875,
      "2024-05-01T19:30:00+00:00": 235.9199981689453
    },
    "sentiment": 0.9181686043739319
  },
  {
    "title": "Noteworthy Tuesday Option Activity: CRL, CHPT, DIS",
    "published": 1715659740,
    "day_prices": {
      "2024-05-14T13:30:00+00:00": 230.30999755859375,
      "2024-05-14T14:30:00+00:00": 230.00999450683594,
      "2024-05-14T15:30:00+00:00": 231.86459350585938,
      "2024-05-14T16:30:00+00:00": 231.9149932861328,
      "2024-05-14T17:30:00+00:00": 231.10000610351562,
      "2024-05-14T18:30:00+00:00": 230.55999755859375,
      "2024-05-14T19:30:00+00:00": 232.69000244140625
    },
    "sentiment": 0.917302131652832
  },
  {
    "title": "Why Charles River Laboratories (CRL) is a Top Value Stock for the Long-Term",
    "published": 1715607611,
    "day_prices": {
      "2024-05-13T13:30:00+00:00": 228.05999755859375,
      "2024-05-13T14:30:00+00:00": 226.5749969482422,
      "2024-05-13T15:30:00+00:00": 228.51499938964844,
      "2024-05-13T16:30:00+00:00": 228.3699951171875,
      "2024-05-13T17:30:00+00:00": 226.94439697265625,
      "2024-05-13T18:30:00+00:00": 228.49000549316406,
      "2024-05-13T19:30:00+00:00": 227.42999267578125
    },
    "sentiment": 0.7942818999290466
  },
  {
    "title": "Charles River price target lowered by $32 at TD Cowen, here's why",
    "published": 1715581500,
    "day_prices": {
      "2024-05-13T13:30:00+00:00": 228.05999755859375,
      "2024-05-13T14:30:00+00:00": 226.5749969482422,
      "2024-05-13T15:30:00+00:00": 228.51499938964844,
      "2024-05-13T16:30:00+00:00": 228.3699951171875,
      "2024-05-13T17:30:00+00:00": 226.94439697265625,
      "2024-05-13T18:30:00+00:00": 228.49000549316406,
      "2024-05-13T19:30:00+00:00": 227.42999267578125
    },
    "sentiment": 0.8343600034713745
  },
  {
    "title": "Charles River Laboratories International, Inc. (NYSE:CRL) Q1 2024 Earnings Call Transcript",
    "published": 1715371581,
    "day_prices": {
      "2024-05-10T13:30:00+00:00": 230.25999450683594,
      "2024-05-10T14:30:00+00:00": 225.47999572753906,
      "2024-05-10T15:30:00+00:00": 225.67999267578125,
      "2024-05-10T16:30:00+00:00": 226.27999877929688,
      "2024-05-10T17:30:00+00:00": 227.0399932861328,
      "2024-05-10T18:30:00+00:00": 226.06500244140625,
      "2024-05-10T19:30:00+00:00": 227.35000610351562
    },
    "sentiment": 0.8993646502494812
  },
  {
    "title": "The Analyst Landscape: 7 Takes On Charles River",
    "published": 1715324520,
    "day_prices": {
      "2024-05-10T13:30:00+00:00": 230.25999450683594,
      "2024-05-10T14:30:00+00:00": 225.47999572753906,
      "2024-05-10T15:30:00+00:00": 225.67999267578125,
      "2024-05-10T16:30:00+00:00": 226.27999877929688,
      "2024-05-10T17:30:00+00:00": 227.0399932861328,
      "2024-05-10T18:30:00+00:00": 226.06500244140625,
      "2024-05-10T19:30:00+00:00": 227.35000610351562
    },
    "sentiment": 0.9208675622940063
  },
  {
    "title": "Decoding Charles River Laboratories International Inc (CRL): A Strategic SWOT Insight",
    "published": 1715317397,
    "day_prices": {
      "2024-05-10T13:30:00+00:00": 230.25999450683594,
      "2024-05-10T14:30:00+00:00": 225.47999572753906,
      "2024-05-10T15:30:00+00:00": 225.67999267578125,
      "2024-05-10T16:30:00+00:00": 226.27999877929688,
      "2024-05-10T17:30:00+00:00": 227.0399932861328,
      "2024-05-10T18:30:00+00:00": 226.06500244140625,
      "2024-05-10T19:30:00+00:00": 227.35000610351562
    },
    "sentiment": 0.869429349899292
  },
  {
    "title": "Q1 2024 Charles River Laboratories International Inc Earnings Call",
    "published": 1715311328,
    "day_prices": {
      "2024-05-10T13:30:00+00:00": 230.25999450683594,
      "2024-05-10T14:30:00+00:00": 225.47999572753906,
      "2024-05-10T15:30:00+00:00": 225.67999267578125,
      "2024-05-10T16:30:00+00:00": 226.27999877929688,
      "2024-05-10T17:30:00+00:00": 227.0399932861328,
      "2024-05-10T18:30:00+00:00": 226.06500244140625,
      "2024-05-10T19:30:00+00:00": 227.35000610351562
    },
    "sentiment": 0.7603397369384766
  },
  {
    "title": "Charles River (CRL) Q1 Earnings: Taking a Look at Key Metrics Versus Estimates",
    "published": 1715261426,
    "day_prices": {
      "2024-05-09T13:30:00+00:00": 236.0,
      "2024-05-09T14:30:00+00:00": 235.9149932861328,
      "2024-05-09T15:30:00+00:00": 229.64999389648438,
      "2024-05-09T16:30:00+00:00": 228.27000427246094,
      "2024-05-09T17:30:00+00:00": 229.0500030517578,
      "2024-05-09T18:30:00+00:00": 226.5,
      "2024-05-09T19:30:00+00:00": 230.39999389648438
    },
    "sentiment": 0.8972133994102478
  },
  {
    "title": "Charles River beats first-quarter estimates, reaffirms annual forecast",
    "published": 1715257120,
    "day_prices": {
      "2024-05-09T13:30:00+00:00": 236.0,
      "2024-05-09T14:30:00+00:00": 235.9149932861328,
      "2024-05-09T15:30:00+00:00": 229.64999389648438,
      "2024-05-09T16:30:00+00:00": 228.27000427246094,
      "2024-05-09T17:30:00+00:00": 229.0500030517578,
      "2024-05-09T18:30:00+00:00": 226.5,
      "2024-05-09T19:30:00+00:00": 230.39999389648438
    },
    "sentiment": 0.7871741652488708
  },
  {
    "title": "CRL Stock Earnings: Charles River Beats EPS, Beats Revenue for Q1 2024",
    "published": 1715252340,
    "day_prices": {
      "2024-05-09T13:30:00+00:00": 236.0,
      "2024-05-09T14:30:00+00:00": 235.9149932861328,
      "2024-05-09T15:30:00+00:00": 229.64999389648438,
      "2024-05-09T16:30:00+00:00": 228.27000427246094,
      "2024-05-09T17:30:00+00:00": 229.0500030517578,
      "2024-05-09T18:30:00+00:00": 226.5,
      "2024-05-09T19:30:00+00:00": 230.39999389648438
    },
    "sentiment": 0.5774694085121155
  },
  {
    "title": "Charles River: Q1 Earnings Snapshot",
    "published": 1715238800,
    "day_prices": {
      "2024-05-09T13:30:00+00:00": 236.0,
      "2024-05-09T14:30:00+00:00": 235.9149932861328,
      "2024-05-09T15:30:00+00:00": 229.64999389648438,
      "2024-05-09T16:30:00+00:00": 228.27000427246094,
      "2024-05-09T17:30:00+00:00": 229.0500030517578,
      "2024-05-09T18:30:00+00:00": 226.5,
      "2024-05-09T19:30:00+00:00": 230.39999389648438
    },
    "sentiment": 0.5364676713943481
  },
  {
    "title": "Charles River backs FY24 EPS view $10.90-$11.40, consensus $11.02",
    "published": 1715235540,
    "day_prices": {
      "2024-05-09T13:30:00+00:00": 236.0,
      "2024-05-09T14:30:00+00:00": 235.9149932861328,
      "2024-05-09T15:30:00+00:00": 229.64999389648438,
      "2024-05-09T16:30:00+00:00": 228.27000427246094,
      "2024-05-09T17:30:00+00:00": 229.0500030517578,
      "2024-05-09T18:30:00+00:00": 226.5,
      "2024-05-09T19:30:00+00:00": 230.39999389648438
    },
    "sentiment": 0.4783754348754883
  },
  {
    "title": "Charles River Laboratories International files automatic mixed shelf",
    "published": 1715226660,
    "day_prices": {
      "2024-05-09T13:30:00+00:00": 236.0,
      "2024-05-09T14:30:00+00:00": 235.9149932861328,
      "2024-05-09T15:30:00+00:00": 229.64999389648438,
      "2024-05-09T16:30:00+00:00": 228.27000427246094,
      "2024-05-09T17:30:00+00:00": 229.0500030517578,
      "2024-05-09T18:30:00+00:00": 226.5,
      "2024-05-09T19:30:00+00:00": 230.39999389648438
    },
    "sentiment": 0.9314733743667603
  },
  {
    "title": "The 7 Best Growth Stocks to Buy in May 2024",
    "published": 1715162400,
    "day_prices": {
      "2024-05-08T13:30:00+00:00": 235.27999877929688,
      "2024-05-08T14:30:00+00:00": 235.17999267578125,
      "2024-05-08T15:30:00+00:00": 234.4199981689453,
      "2024-05-08T16:30:00+00:00": 234.65499877929688,
      "2024-05-08T17:30:00+00:00": 234.9600067138672,
      "2024-05-08T18:30:00+00:00": 235.6199951171875,
      "2024-05-08T19:30:00+00:00": 234.3125
    },
    "sentiment": 0.8711119890213013
  },
  {
    "title": "Video: S&P 500 Movers: CRL, WMT",
    "published": 1715851020,
    "day_prices": {
      "2024-05-16T13:30:00+00:00": 230.8300018310547,
      "2024-05-16T14:30:00+00:00": 221.88999938964844,
      "2024-05-16T15:30:00+00:00": 225.6300048828125,
      "2024-05-16T16:30:00+00:00": 226.73500061035156,
      "2024-05-16T17:30:00+00:00": 226.50999450683594,
      "2024-05-16T18:30:00+00:00": 225.5399932861328,
      "2024-05-16T19:30:00+00:00": 225.1300048828125
    },
    "sentiment": 0.9474334716796875
  },
  {
    "title": "Charles River Laboratories: Fair Valuation Against Fundamentals",
    "published": 1717130685,
    "day_prices": {
      "2024-05-31T13:30:00+00:00": 209.89999389648438,
      "2024-05-31T14:30:00+00:00": 207.5500030517578,
      "2024-05-31T15:30:00+00:00": 207.52000427246094,
      "2024-05-31T16:30:00+00:00": 206.97000122070312,
      "2024-05-31T17:30:00+00:00": 208.14999389648438,
      "2024-05-31T18:30:00+00:00": 206.52499389648438,
      "2024-05-31T19:30:00+00:00": 206.72000122070312
    },
    "sentiment": 0.7750275135040283
  },
  {
    "title": "Reasons to Hold Charles River (CRL) in Your Portfolio Now",
    "published": 1717067820,
    "day_prices": {
      "2024-05-30T13:30:00+00:00": 211.13999938964844,
      "2024-05-30T14:30:00+00:00": 211.08999633789062,
      "2024-05-30T15:30:00+00:00": 211.625,
      "2024-05-30T16:30:00+00:00": 211.69000244140625,
      "2024-05-30T17:30:00+00:00": 211.4499969482422,
      "2024-05-30T18:30:00+00:00": 210.49000549316406,
      "2024-05-30T19:30:00+00:00": 209.82000732421875
    },
    "sentiment": 0.9390405416488647
  },
  {
    "title": "Barclays Initiates Coverage of Charles River Laboratories International (CRL) with Equal-Weight Recommendation",
    "published": 1719641113,
    "day_prices": {},
    "sentiment": 0.5332350730895996
  },
  {
    "title": "Nike and Alphabet downgraded: Wall Street's top analyst calls",
    "published": 1719563640,
    "day_prices": {
      "2024-06-28T13:30:00+00:00": 205.9199981689453,
      "2024-06-28T14:30:00+00:00": 207.3300018310547,
      "2024-06-28T15:30:00+00:00": 207.91000366210938,
      "2024-06-28T16:30:00+00:00": 207.9250030517578,
      "2024-06-28T17:30:00+00:00": 206.4499969482422,
      "2024-06-28T18:30:00+00:00": 205.7899932861328,
      "2024-06-28T19:30:00+00:00": 205.10000610351562
    },
    "sentiment": 0.7494624257087708
  },
  {
    "title": "Demystifying Charles River: Insights From 4 Analyst Reviews",
    "published": 1719561840,
    "day_prices": {
      "2024-06-28T13:30:00+00:00": 205.9199981689453,
      "2024-06-28T14:30:00+00:00": 207.3300018310547,
      "2024-06-28T15:30:00+00:00": 207.91000366210938,
      "2024-06-28T16:30:00+00:00": 207.9250030517578,
      "2024-06-28T17:30:00+00:00": 206.4499969482422,
      "2024-06-28T18:30:00+00:00": 205.7899932861328,
      "2024-06-28T19:30:00+00:00": 205.10000610351562
    },
    "sentiment": 0.8657349348068237
  },
  {
    "title": "Charles River's (CRL) RMS Growth Aids Amid FX Headwind",
    "published": 1719498180,
    "day_prices": {
      "2024-06-27T13:30:00+00:00": 205.41000366210938,
      "2024-06-27T14:30:00+00:00": 206.27999877929688,
      "2024-06-27T15:30:00+00:00": 206.8000030517578,
      "2024-06-27T16:30:00+00:00": 207.0,
      "2024-06-27T17:30:00+00:00": 207.17999267578125,
      "2024-06-27T18:30:00+00:00": 206.00999450683594,
      "2024-06-27T19:30:00+00:00": 206.7949981689453
    },
    "sentiment": 0.9458063244819641
  },
  {
    "title": "Charles River initiated with neutral view at Barclays, here's why",
    "published": 1719465240,
    "day_prices": {
      "2024-06-27T13:30:00+00:00": 205.41000366210938,
      "2024-06-27T14:30:00+00:00": 206.27999877929688,
      "2024-06-27T15:30:00+00:00": 206.8000030517578,
      "2024-06-27T16:30:00+00:00": 207.0,
      "2024-06-27T17:30:00+00:00": 207.17999267578125,
      "2024-06-27T18:30:00+00:00": 206.00999450683594,
      "2024-06-27T19:30:00+00:00": 206.7949981689453
    },
    "sentiment": 0.9164741635322571
  },
  {
    "title": "Charles River Laboratories Announces Strategic Lentiviral Vector Manufacturing Collaboration with Gates Institute at University of Colorado Anschutz Medical Campus",
    "published": 1719316800,
    "day_prices": {
      "2024-06-25T13:30:00+00:00": 209.16000366210938,
      "2024-06-25T14:30:00+00:00": 208.0800018310547,
      "2024-06-25T15:30:00+00:00": 205.3000030517578,
      "2024-06-25T16:30:00+00:00": 205.3699951171875,
      "2024-06-25T17:30:00+00:00": 205.0500030517578,
      "2024-06-25T18:30:00+00:00": 204.8925018310547,
      "2024-06-25T19:30:00+00:00": 204.4499969482422
    },
    "sentiment": 0.8550195693969727
  },
  {
    "title": "\u2018The CRO Sector Looks Appealing,\u2019 Says Goldman Sachs \u2014 Here Are 2 Stocks to Consider",
    "published": 1718714961,
    "day_prices": {
      "2024-06-18T13:30:00+00:00": 208.9499969482422,
      "2024-06-18T14:30:00+00:00": 208.21499633789062,
      "2024-06-18T15:30:00+00:00": 210.16000366210938,
      "2024-06-18T16:30:00+00:00": 209.27499389648438,
      "2024-06-18T17:30:00+00:00": 207.3699951171875,
      "2024-06-18T18:30:00+00:00": 207.44500732421875,
      "2024-06-18T19:30:00+00:00": 209.39999389648438
    },
    "sentiment": 0.8828693628311157
  },
  {
    "title": "Mizuho Securities Sticks to Its Hold Rating for Charles River Labs (CRL)",
    "published": 1718710740,
    "day_prices": {
      "2024-06-18T13:30:00+00:00": 208.9499969482422,
      "2024-06-18T14:30:00+00:00": 208.21499633789062,
      "2024-06-18T15:30:00+00:00": 210.16000366210938,
      "2024-06-18T16:30:00+00:00": 209.27499389648438,
      "2024-06-18T17:30:00+00:00": 207.3699951171875,
      "2024-06-18T18:30:00+00:00": 207.44500732421875,
      "2024-06-18T19:30:00+00:00": 209.39999389648438
    },
    "sentiment": 0.7843726277351379
  },
  {
    "title": "Charles River and Captain T Cell Announce Plasmid DNA and Viral Vector Manufacturing Alliance for Gene-Modified Cell Therapy",
    "published": 1718625600,
    "day_prices": {
      "2024-06-17T13:30:00+00:00": 208.22999572753906,
      "2024-06-17T14:30:00+00:00": 207.88499450683594,
      "2024-06-17T15:30:00+00:00": 208.30999755859375,
      "2024-06-17T16:30:00+00:00": 208.57000732421875,
      "2024-06-17T17:30:00+00:00": 207.89999389648438,
      "2024-06-17T18:30:00+00:00": 208.6300048828125,
      "2024-06-17T19:30:00+00:00": 208.7476043701172
    },
    "sentiment": 0.6854864358901978
  },
  {
    "title": "Tracking John Rogers' Ariel Investments Portfolio - Q1 2024 Update",
    "published": 1718134756,
    "day_prices": {
      "2024-06-11T13:30:00+00:00": 212.77000427246094,
      "2024-06-11T14:30:00+00:00": 211.16000366210938,
      "2024-06-11T15:30:00+00:00": 210.58999633789062,
      "2024-06-11T16:30:00+00:00": 210.07000732421875,
      "2024-06-11T17:30:00+00:00": 210.47999572753906,
      "2024-06-11T18:30:00+00:00": 210.83999633789062,
      "2024-06-11T19:30:00+00:00": 209.7899932861328
    },
    "sentiment": 0.9464010000228882
  },
  {
    "title": "Charles River Laboratories, in Collaboration With MatTek Corporation, Awarded Grant from the Foundation for Chemistry Research and Initiatives to Advance Research Alternatives",
    "published": 1718107200,
    "day_prices": {
      "2024-06-11T13:30:00+00:00": 212.77000427246094,
      "2024-06-11T14:30:00+00:00": 211.16000366210938,
      "2024-06-11T15:30:00+00:00": 210.58999633789062,
      "2024-06-11T16:30:00+00:00": 210.07000732421875,
      "2024-06-11T17:30:00+00:00": 210.47999572753906,
      "2024-06-11T18:30:00+00:00": 210.83999633789062,
      "2024-06-11T19:30:00+00:00": 209.7899932861328
    },
    "sentiment": 0.9020838141441345
  },
  {
    "title": "Mizuho Initiates Coverage of Charles River Laboratories International (CRL) with Neutral Recommendation",
    "published": 1717768391,
    "day_prices": {
      "2024-06-07T13:30:00+00:00": 219.2100067138672,
      "2024-06-07T14:30:00+00:00": 217.39500427246094,
      "2024-06-07T15:30:00+00:00": 215.9600067138672,
      "2024-06-07T16:30:00+00:00": 215.91000366210938,
      "2024-06-07T17:30:00+00:00": 216.0399932861328,
      "2024-06-07T18:30:00+00:00": 215.22000122070312,
      "2024-06-07T19:30:00+00:00": 215.39999389648438
    },
    "sentiment": 0.5539113283157349
  },
  {
    "title": "Hold Rating on Charles River Labs Amid Near-Term Visibility and Valuation Concerns",
    "published": 1717738020,
    "day_prices": {
      "2024-06-07T13:30:00+00:00": 219.2100067138672,
      "2024-06-07T14:30:00+00:00": 217.39500427246094,
      "2024-06-07T15:30:00+00:00": 215.9600067138672,
      "2024-06-07T16:30:00+00:00": 215.91000366210938,
      "2024-06-07T17:30:00+00:00": 216.0399932861328,
      "2024-06-07T18:30:00+00:00": 215.22000122070312,
      "2024-06-07T19:30:00+00:00": 215.39999389648438
    },
    "sentiment": 0.9625389575958252
  },
  {
    "title": "Goldman Sachs Initiates Coverage of Charles River Laboratories International (CRL) with Buy Recommendation",
    "published": 1717689260,
    "day_prices": {
      "2024-06-06T13:30:00+00:00": 217.6199951171875,
      "2024-06-06T14:30:00+00:00": 221.22999572753906,
      "2024-06-06T15:30:00+00:00": 220.55999755859375,
      "2024-06-06T16:30:00+00:00": 220.6999969482422,
      "2024-06-06T17:30:00+00:00": 221.67999267578125,
      "2024-06-06T18:30:00+00:00": 221.94000244140625,
      "2024-06-06T19:30:00+00:00": 221.7899932861328
    },
    "sentiment": 0.7558335661888123
  },
  {
    "title": "Why Investors Are Eyeing Charles River Laboratories International Inc (CRL): The Key Drivers of ...",
    "published": 1717668120,
    "day_prices": {
      "2024-06-06T13:30:00+00:00": 217.6199951171875,
      "2024-06-06T14:30:00+00:00": 221.22999572753906,
      "2024-06-06T15:30:00+00:00": 220.55999755859375,
      "2024-06-06T16:30:00+00:00": 220.6999969482422,
      "2024-06-06T17:30:00+00:00": 221.67999267578125,
      "2024-06-06T18:30:00+00:00": 221.94000244140625,
      "2024-06-06T19:30:00+00:00": 221.7899932861328
    },
    "sentiment": 0.898431122303009
  },
  {
    "title": "The Analyst Verdict: Charles River In The Eyes Of 4 Experts",
    "published": 1717661160,
    "day_prices": {
      "2024-06-06T13:30:00+00:00": 217.6199951171875,
      "2024-06-06T14:30:00+00:00": 221.22999572753906,
      "2024-06-06T15:30:00+00:00": 220.55999755859375,
      "2024-06-06T16:30:00+00:00": 220.6999969482422,
      "2024-06-06T17:30:00+00:00": 221.67999267578125,
      "2024-06-06T18:30:00+00:00": 221.94000244140625,
      "2024-06-06T19:30:00+00:00": 221.7899932861328
    },
    "sentiment": 0.7878180742263794
  },
  {
    "title": "Charles River initiated with bullish view at Goldman Sachs, here's why",
    "published": 1717645380,
    "day_prices": {
      "2024-06-06T13:30:00+00:00": 217.6199951171875,
      "2024-06-06T14:30:00+00:00": 221.22999572753906,
      "2024-06-06T15:30:00+00:00": 220.55999755859375,
      "2024-06-06T16:30:00+00:00": 220.6999969482422,
      "2024-06-06T17:30:00+00:00": 221.67999267578125,
      "2024-06-06T18:30:00+00:00": 221.94000244140625,
      "2024-06-06T19:30:00+00:00": 221.7899932861328
    },
    "sentiment": 0.8524910807609558
  },
  {
    "title": "Medpace: Clear Winner If China Blockade Succeeds",
    "published": 1717517556,
    "day_prices": {
      "2024-06-04T13:30:00+00:00": 207.38999938964844,
      "2024-06-04T14:30:00+00:00": 208.63999938964844,
      "2024-06-04T15:30:00+00:00": 208.0449981689453,
      "2024-06-04T16:30:00+00:00": 207.30499267578125,
      "2024-06-04T17:30:00+00:00": 207.41000366210938,
      "2024-06-04T18:30:00+00:00": 208.44000244140625,
      "2024-06-04T19:30:00+00:00": 208.75999450683594
    },
    "sentiment": 0.8128306865692139
  },
  {
    "title": "Charles River announces launch of VCG initiative with Sanofi",
    "published": 1717485000,
    "day_prices": {
      "2024-06-04T13:30:00+00:00": 207.38999938964844,
      "2024-06-04T14:30:00+00:00": 208.63999938964844,
      "2024-06-04T15:30:00+00:00": 208.0449981689453,
      "2024-06-04T16:30:00+00:00": 207.30499267578125,
      "2024-06-04T17:30:00+00:00": 207.41000366210938,
      "2024-06-04T18:30:00+00:00": 208.44000244140625,
      "2024-06-04T19:30:00+00:00": 208.75999450683594
    },
    "sentiment": 0.6682001948356628
  },
  {
    "title": "Charles River Collaborates with Patient Advocacy Group, FOXG1 Research Foundation to Advance Rare Disease Gene Therapy Development",
    "published": 1722340800,
    "day_prices": {
      "2024-07-30T13:30:00+00:00": 239.72999572753906,
      "2024-07-30T14:30:00+00:00": 243.64500427246094,
      "2024-07-30T15:30:00+00:00": 242.9199981689453,
      "2024-07-30T16:30:00+00:00": 242.94000244140625,
      "2024-07-30T17:30:00+00:00": 243.00999450683594,
      "2024-07-30T18:30:00+00:00": 245.13999938964844,
      "2024-07-30T19:30:00+00:00": 245.72000122070312
    },
    "sentiment": 0.5941839218139648
  },
  {
    "title": "Creightons PLC Reports Major Shareholding Change",
    "published": 1721985540,
    "day_prices": {
      "2024-07-26T13:30:00+00:00": 224.27000427246094,
      "2024-07-26T14:30:00+00:00": 229.52999877929688,
      "2024-07-26T15:30:00+00:00": 230.19500732421875,
      "2024-07-26T16:30:00+00:00": 231.88999938964844,
      "2024-07-26T17:30:00+00:00": 231.59500122070312,
      "2024-07-26T18:30:00+00:00": 231.3000030517578,
      "2024-07-26T19:30:00+00:00": 232.3300018310547
    },
    "sentiment": 0.9317417740821838
  },
  {
    "title": "Creightons Director Sells Shares, Reduces Stake",
    "published": 1721870040,
    "day_prices": {
      "2024-07-25T13:30:00+00:00": 221.00999450683594,
      "2024-07-25T14:30:00+00:00": 219.77999877929688,
      "2024-07-25T15:30:00+00:00": 223.72999572753906,
      "2024-07-25T16:30:00+00:00": 226.25999450683594,
      "2024-07-25T17:30:00+00:00": 226.71499633789062,
      "2024-07-25T18:30:00+00:00": 223.9600067138672,
      "2024-07-25T19:30:00+00:00": 221.67999267578125
    },
    "sentiment": 0.48689398169517517
  },
  {
    "title": "Charles River Laboratories and Autobahn Labs Announce Collaborative Program to Accelerate Academic Drug Discovery",
    "published": 1721822400,
    "day_prices": {
      "2024-07-24T13:30:00+00:00": 220.07000732421875,
      "2024-07-24T14:30:00+00:00": 222.1699981689453,
      "2024-07-24T15:30:00+00:00": 223.8800048828125,
      "2024-07-24T16:30:00+00:00": 224.5500030517578,
      "2024-07-24T17:30:00+00:00": 223.25,
      "2024-07-24T18:30:00+00:00": 222.8800048828125,
      "2024-07-24T19:30:00+00:00": 222.47500610351562
    },
    "sentiment": 0.8863523602485657
  },
  {
    "title": "Kepler Capital  Sticks to Its Hold Rating for Carel Industries SpA (CIG)",
    "published": 1721810880,
    "day_prices": {
      "2024-07-24T13:30:00+00:00": 220.07000732421875,
      "2024-07-24T14:30:00+00:00": 222.1699981689453,
      "2024-07-24T15:30:00+00:00": 223.8800048828125,
      "2024-07-24T16:30:00+00:00": 224.5500030517578,
      "2024-07-24T17:30:00+00:00": 223.25,
      "2024-07-24T18:30:00+00:00": 222.8800048828125,
      "2024-07-24T19:30:00+00:00": 222.47500610351562
    },
    "sentiment": 0.7436781525611877
  },
  {
    "title": "ClearBridge Select Strategy Q2 2024 Commentary",
    "published": 1721355300,
    "day_prices": {
      "2024-07-19T13:30:00+00:00": 219.22999572753906,
      "2024-07-19T14:30:00+00:00": 216.77999877929688,
      "2024-07-19T15:30:00+00:00": 215.65499877929688,
      "2024-07-19T16:30:00+00:00": 216.82000732421875,
      "2024-07-19T17:30:00+00:00": 218.66000366210938,
      "2024-07-19T18:30:00+00:00": 217.41000366210938,
      "2024-07-19T19:30:00+00:00": 218.25
    },
    "sentiment": 0.938058614730835
  },
  {
    "title": "Creightons PLC Reports Resilient Financial Performance",
    "published": 1721268300,
    "day_prices": {
      "2024-07-18T13:30:00+00:00": 221.4600067138672,
      "2024-07-18T14:30:00+00:00": 225.72000122070312,
      "2024-07-18T15:30:00+00:00": 222.52000427246094,
      "2024-07-18T16:30:00+00:00": 220.75999450683594,
      "2024-07-18T17:30:00+00:00": 219.4499969482422,
      "2024-07-18T18:30:00+00:00": 217.24000549316406,
      "2024-07-18T19:30:00+00:00": 218.1999969482422
    },
    "sentiment": 0.9411681294441223
  },
  {
    "title": "Riverwater Sustainable Value Strategy Q2 2024 Commentary",
    "published": 1721132100,
    "day_prices": {
      "2024-07-16T13:30:00+00:00": 217.27000427246094,
      "2024-07-16T14:30:00+00:00": 222.41000366210938,
      "2024-07-16T15:30:00+00:00": 223.25999450683594,
      "2024-07-16T16:30:00+00:00": 225.39999389648438,
      "2024-07-16T17:30:00+00:00": 225.8300018310547,
      "2024-07-16T18:30:00+00:00": 226.64999389648438,
      "2024-07-16T19:30:00+00:00": 227.92999267578125
    },
    "sentiment": 0.9239232540130615
  },
  {
    "title": "Charles River to Perform Plasmid Manufacturing for AAVantgarde",
    "published": 1720440000,
    "day_prices": {
      "2024-07-08T13:30:00+00:00": 201.52999877929688,
      "2024-07-08T14:30:00+00:00": 199.17999267578125,
      "2024-07-08T15:30:00+00:00": 198.94000244140625,
      "2024-07-08T16:30:00+00:00": 200.63999938964844,
      "2024-07-08T17:30:00+00:00": 202.80999755859375,
      "2024-07-08T18:30:00+00:00": 203.38999938964844,
      "2024-07-08T19:30:00+00:00": 202.22999572753906
    },
    "sentiment": 0.8933908939361572
  },
  {
    "title": "What's Driving Exact Sciences Corp's Surprising 32% Stock Rally?",
    "published": 1724840280,
    "day_prices": {
      "2024-08-28T13:30:00+00:00": 202.74000549316406,
      "2024-08-28T14:30:00+00:00": 202.69000244140625,
      "2024-08-28T15:30:00+00:00": 200.7100067138672,
      "2024-08-28T16:30:00+00:00": 199.10000610351562,
      "2024-08-28T17:30:00+00:00": 198.50999450683594,
      "2024-08-28T18:30:00+00:00": 196.8300018310547,
      "2024-08-28T19:30:00+00:00": 197.30999755859375
    },
    "sentiment": 0.8871161937713623
  },
  {
    "title": "Charles River Laboratories International (CRL) Price Target Decreased by 11.86% to 229.08",
    "published": 1724645790,
    "day_prices": {
      "2024-08-26T13:30:00+00:00": 206.0,
      "2024-08-26T14:30:00+00:00": 205.7449951171875,
      "2024-08-26T15:30:00+00:00": 204.5,
      "2024-08-26T16:30:00+00:00": 204.14999389648438,
      "2024-08-26T17:30:00+00:00": 204.13999938964844,
      "2024-08-26T18:30:00+00:00": 203.0373992919922,
      "2024-08-26T19:30:00+00:00": 204.07000732421875
    },
    "sentiment": 0.9679322242736816
  },
  {
    "title": "Charles River Laboratories: Changing Economics Reduces Compounding Ability (Rating Downgrade)",
    "published": 1723703514,
    "day_prices": {
      "2024-08-15T13:30:00+00:00": 202.75999450683594,
      "2024-08-15T14:30:00+00:00": 203.17999267578125,
      "2024-08-15T15:30:00+00:00": 203.97000122070312,
      "2024-08-15T16:30:00+00:00": 203.88999938964844,
      "2024-08-15T17:30:00+00:00": 203.3800048828125,
      "2024-08-15T18:30:00+00:00": 202.47500610351562,
      "2024-08-15T19:30:00+00:00": 202.97999572753906
    },
    "sentiment": 0.9359450936317444
  },
  {
    "title": "Hold Rating on Charles River Labs Amidst Pharma Restructuring and Uncertain Near-Term Earnings",
    "published": 1723550340,
    "day_prices": {
      "2024-08-13T13:30:00+00:00": 194.67999267578125,
      "2024-08-13T14:30:00+00:00": 198.63999938964844,
      "2024-08-13T15:30:00+00:00": 199.58999633789062,
      "2024-08-13T16:30:00+00:00": 201.69000244140625,
      "2024-08-13T17:30:00+00:00": 200.9499969482422,
      "2024-08-13T18:30:00+00:00": 199.65499877929688,
      "2024-08-13T19:30:00+00:00": 201.72000122070312
    },
    "sentiment": 0.9578360915184021
  },
  {
    "title": "Why Charles River (CRL) International Revenue Trends Deserve Your Attention",
    "published": 1723468538,
    "day_prices": {
      "2024-08-12T13:30:00+00:00": 199.52000427246094,
      "2024-08-12T14:30:00+00:00": 196.0399932861328,
      "2024-08-12T15:30:00+00:00": 195.6199951171875,
      "2024-08-12T16:30:00+00:00": 196.94500732421875,
      "2024-08-12T17:30:00+00:00": 197.8350067138672,
      "2024-08-12T18:30:00+00:00": 196.49000549316406,
      "2024-08-12T19:30:00+00:00": 197.51499938964844
    },
    "sentiment": 0.8882745504379272
  },
  {
    "title": "Charles River price target lowered by $25 at TD Cowen, here's why",
    "published": 1723444620,
    "day_prices": {
      "2024-08-12T13:30:00+00:00": 199.52000427246094,
      "2024-08-12T14:30:00+00:00": 196.0399932861328,
      "2024-08-12T15:30:00+00:00": 195.6199951171875,
      "2024-08-12T16:30:00+00:00": 196.94500732421875,
      "2024-08-12T17:30:00+00:00": 197.8350067138672,
      "2024-08-12T18:30:00+00:00": 196.49000549316406,
      "2024-08-12T19:30:00+00:00": 197.51499938964844
    },
    "sentiment": 0.8402933478355408
  },
  {
    "title": "Analysts Offer Insights on Healthcare Companies: AnaptysBio (ANAB), Charles River Labs (CRL) and Akero Therapeutics (AKRO)",
    "published": 1723440960,
    "day_prices": {
      "2024-08-12T13:30:00+00:00": 199.52000427246094,
      "2024-08-12T14:30:00+00:00": 196.0399932861328,
      "2024-08-12T15:30:00+00:00": 195.6199951171875,
      "2024-08-12T16:30:00+00:00": 196.94500732421875,
      "2024-08-12T17:30:00+00:00": 197.8350067138672,
      "2024-08-12T18:30:00+00:00": 196.49000549316406,
      "2024-08-12T19:30:00+00:00": 197.51499938964844
    },
    "sentiment": 0.9142051935195923
  },
  {
    "title": "Charles River Laboratories: Q2, Cost Structure Streamlining (Rating Upgrade)",
    "published": 1723280400,
    "day_prices": {},
    "sentiment": 0.7489573955535889
  },
  {
    "title": "ClearBridge Mid Cap Growth Strategy Q2 2024 Commentary",
    "published": 1723185600,
    "day_prices": {
      "2024-08-09T13:30:00+00:00": 203.77000427246094,
      "2024-08-09T14:30:00+00:00": 201.17999267578125,
      "2024-08-09T15:30:00+00:00": 203.38999938964844,
      "2024-08-09T16:30:00+00:00": 202.55499267578125,
      "2024-08-09T17:30:00+00:00": 203.1699981689453,
      "2024-08-09T18:30:00+00:00": 199.97000122070312,
      "2024-08-09T19:30:00+00:00": 199.15499877929688
    },
    "sentiment": 0.8823595643043518
  },
  {
    "title": "JP Morgan Downgrades Charles River Laboratories International (CRL)",
    "published": 1723141528,
    "day_prices": {
      "2024-08-08T13:30:00+00:00": 191.5,
      "2024-08-08T14:30:00+00:00": 201.0800018310547,
      "2024-08-08T15:30:00+00:00": 201.02000427246094,
      "2024-08-08T16:30:00+00:00": 199.30999755859375,
      "2024-08-08T17:30:00+00:00": 198.99000549316406,
      "2024-08-08T18:30:00+00:00": 199.2050018310547,
      "2024-08-08T19:30:00+00:00": 199.06500244140625
    },
    "sentiment": 0.8042873740196228
  },
  {
    "title": "Charles River price target lowered by $60 at Deutsche Bank, here's why",
    "published": 1723106040,
    "day_prices": {
      "2024-08-08T13:30:00+00:00": 191.5,
      "2024-08-08T14:30:00+00:00": 201.0800018310547,
      "2024-08-08T15:30:00+00:00": 201.02000427246094,
      "2024-08-08T16:30:00+00:00": 199.30999755859375,
      "2024-08-08T17:30:00+00:00": 198.99000549316406,
      "2024-08-08T18:30:00+00:00": 199.2050018310547,
      "2024-08-08T19:30:00+00:00": 199.06500244140625
    },
    "sentiment": 0.8672559857368469
  },
  {
    "title": "EXCLUSIVE: Oragenics' Concussion Drug Clears FDA-Required Cardiotoxicity Testing, Planning For Phase Trials Underway",
    "published": 1723102500,
    "day_prices": {
      "2024-08-08T13:30:00+00:00": 191.5,
      "2024-08-08T14:30:00+00:00": 201.0800018310547,
      "2024-08-08T15:30:00+00:00": 201.02000427246094,
      "2024-08-08T16:30:00+00:00": 199.30999755859375,
      "2024-08-08T17:30:00+00:00": 198.99000549316406,
      "2024-08-08T18:30:00+00:00": 199.2050018310547,
      "2024-08-08T19:30:00+00:00": 199.06500244140625
    },
    "sentiment": 0.633894145488739
  },
  {
    "title": "Barclays Keeps Their Hold Rating on Charles River Labs (CRL)",
    "published": 1723101420,
    "day_prices": {
      "2024-08-08T13:30:00+00:00": 191.5,
      "2024-08-08T14:30:00+00:00": 201.0800018310547,
      "2024-08-08T15:30:00+00:00": 201.02000427246094,
      "2024-08-08T16:30:00+00:00": 199.30999755859375,
      "2024-08-08T17:30:00+00:00": 198.99000549316406,
      "2024-08-08T18:30:00+00:00": 199.2050018310547,
      "2024-08-08T19:30:00+00:00": 199.06500244140625
    },
    "sentiment": 0.9250905513763428
  },
  {
    "title": "Critical Insights From Charles River Analyst Ratings: What You Need To Know",
    "published": 1723100820,
    "day_prices": {
      "2024-08-08T13:30:00+00:00": 191.5,
      "2024-08-08T14:30:00+00:00": 201.0800018310547,
      "2024-08-08T15:30:00+00:00": 201.02000427246094,
      "2024-08-08T16:30:00+00:00": 199.30999755859375,
      "2024-08-08T17:30:00+00:00": 198.99000549316406,
      "2024-08-08T18:30:00+00:00": 199.2050018310547,
      "2024-08-08T19:30:00+00:00": 199.06500244140625
    },
    "sentiment": 0.9363741278648376
  },
  {
    "title": "Maintaining Buy on Charles River Labs Amid Adjusted Expectations and Market Headwinds",
    "published": 1723098780,
    "day_prices": {
      "2024-08-08T13:30:00+00:00": 191.5,
      "2024-08-08T14:30:00+00:00": 201.0800018310547,
      "2024-08-08T15:30:00+00:00": 201.02000427246094,
      "2024-08-08T16:30:00+00:00": 199.30999755859375,
      "2024-08-08T17:30:00+00:00": 198.99000549316406,
      "2024-08-08T18:30:00+00:00": 199.2050018310547,
      "2024-08-08T19:30:00+00:00": 199.06500244140625
    },
    "sentiment": 0.5609502792358398
  },
  {
    "title": "Q2 2024 Charles River Laboratories International Inc Earnings Call",
    "published": 1723093437,
    "day_prices": {
      "2024-08-08T13:30:00+00:00": 191.5,
      "2024-08-08T14:30:00+00:00": 201.0800018310547,
      "2024-08-08T15:30:00+00:00": 201.02000427246094,
      "2024-08-08T16:30:00+00:00": 199.30999755859375,
      "2024-08-08T17:30:00+00:00": 198.99000549316406,
      "2024-08-08T18:30:00+00:00": 199.2050018310547,
      "2024-08-08T19:30:00+00:00": 199.06500244140625
    },
    "sentiment": 0.7473657727241516
  },
  {
    "title": "Charles River just downgraded at Baird, here's why",
    "published": 1723090020,
    "day_prices": {
      "2024-08-08T13:30:00+00:00": 191.5,
      "2024-08-08T14:30:00+00:00": 201.0800018310547,
      "2024-08-08T15:30:00+00:00": 201.02000427246094,
      "2024-08-08T16:30:00+00:00": 199.30999755859375,
      "2024-08-08T17:30:00+00:00": 198.99000549316406,
      "2024-08-08T18:30:00+00:00": 199.2050018310547,
      "2024-08-08T19:30:00+00:00": 199.06500244140625
    },
    "sentiment": 0.8459665775299072
  },
  {
    "title": "Charles River price target lowered by $20 at Morgan Stanley, here's why",
    "published": 1723081200,
    "day_prices": {
      "2024-08-08T13:30:00+00:00": 191.5,
      "2024-08-08T14:30:00+00:00": 201.0800018310547,
      "2024-08-08T15:30:00+00:00": 201.02000427246094,
      "2024-08-08T16:30:00+00:00": 199.30999755859375,
      "2024-08-08T17:30:00+00:00": 198.99000549316406,
      "2024-08-08T18:30:00+00:00": 199.2050018310547,
      "2024-08-08T19:30:00+00:00": 199.06500244140625
    },
    "sentiment": 0.8273495435714722
  },
  {
    "title": "Charles River Labs Says It Expects Sales To Fall, Sending Its Stock Tumbling",
    "published": 1723050414,
    "day_prices": {
      "2024-08-07T13:30:00+00:00": 191.83999633789062,
      "2024-08-07T14:30:00+00:00": 196.0399932861328,
      "2024-08-07T15:30:00+00:00": 201.6699981689453,
      "2024-08-07T16:30:00+00:00": 203.0399932861328,
      "2024-08-07T17:30:00+00:00": 200.0,
      "2024-08-07T18:30:00+00:00": 199.25,
      "2024-08-07T19:30:00+00:00": 200.00999450683594
    },
    "sentiment": 0.9750128388404846
  },
  {
    "title": "Charles River Laboratories International Inc (CRL) Q2 2024 Earnings Call Transcript",
    "published": 1723040461,
    "day_prices": {
      "2024-08-07T13:30:00+00:00": 191.83999633789062,
      "2024-08-07T14:30:00+00:00": 196.0399932861328,
      "2024-08-07T15:30:00+00:00": 201.6699981689453,
      "2024-08-07T16:30:00+00:00": 203.0399932861328,
      "2024-08-07T17:30:00+00:00": 200.0,
      "2024-08-07T18:30:00+00:00": 199.25,
      "2024-08-07T19:30:00+00:00": 200.00999450683594
    },
    "sentiment": 0.919769823551178
  },
  {
    "title": "Charles River cuts 2024 forecast on lower demand for drug development services",
    "published": 1723033546,
    "day_prices": {
      "2024-08-07T13:30:00+00:00": 191.83999633789062,
      "2024-08-07T14:30:00+00:00": 196.0399932861328,
      "2024-08-07T15:30:00+00:00": 201.6699981689453,
      "2024-08-07T16:30:00+00:00": 203.0399932861328,
      "2024-08-07T17:30:00+00:00": 200.0,
      "2024-08-07T18:30:00+00:00": 199.25,
      "2024-08-07T19:30:00+00:00": 200.00999450683594
    },
    "sentiment": 0.9596124887466431
  },
  {
    "title": "Charles River: Q2 Earnings Snapshot",
    "published": 1723028871,
    "day_prices": {
      "2024-08-07T13:30:00+00:00": 191.83999633789062,
      "2024-08-07T14:30:00+00:00": 196.0399932861328,
      "2024-08-07T15:30:00+00:00": 201.6699981689453,
      "2024-08-07T16:30:00+00:00": 203.0399932861328,
      "2024-08-07T17:30:00+00:00": 200.0,
      "2024-08-07T18:30:00+00:00": 199.25,
      "2024-08-07T19:30:00+00:00": 200.00999450683594
    },
    "sentiment": 0.5624043941497803
  },
  {
    "title": "Charles River Laboratories Announces Second-Quarter 2024 Results",
    "published": 1723028400,
    "day_prices": {
      "2024-08-07T13:30:00+00:00": 191.83999633789062,
      "2024-08-07T14:30:00+00:00": 196.0399932861328,
      "2024-08-07T15:30:00+00:00": 201.6699981689453,
      "2024-08-07T16:30:00+00:00": 203.0399932861328,
      "2024-08-07T17:30:00+00:00": 200.0,
      "2024-08-07T18:30:00+00:00": 199.25,
      "2024-08-07T19:30:00+00:00": 200.00999450683594
    },
    "sentiment": 0.8784727454185486
  },
  {
    "title": "CRL Crosses Below Key Moving Average Level",
    "published": 1723025280,
    "day_prices": {
      "2024-08-07T13:30:00+00:00": 191.83999633789062,
      "2024-08-07T14:30:00+00:00": 196.0399932861328,
      "2024-08-07T15:30:00+00:00": 201.6699981689453,
      "2024-08-07T16:30:00+00:00": 203.0399932861328,
      "2024-08-07T17:30:00+00:00": 200.0,
      "2024-08-07T18:30:00+00:00": 199.25,
      "2024-08-07T19:30:00+00:00": 200.00999450683594
    },
    "sentiment": 0.7737406492233276
  },
  {
    "title": "Charles River cuts 2024 forecast as funding crunch among biotech clients persists",
    "published": 1723018976,
    "day_prices": {
      "2024-08-07T13:30:00+00:00": 191.83999633789062,
      "2024-08-07T14:30:00+00:00": 196.0399932861328,
      "2024-08-07T15:30:00+00:00": 201.6699981689453,
      "2024-08-07T16:30:00+00:00": 203.0399932861328,
      "2024-08-07T17:30:00+00:00": 200.0,
      "2024-08-07T18:30:00+00:00": 199.25,
      "2024-08-07T19:30:00+00:00": 200.00999450683594
    },
    "sentiment": 0.9659041166305542
  },
  {
    "title": "Charles River announces new $1B stock repurchase authorization",
    "published": 1723012500,
    "day_prices": {
      "2024-08-07T13:30:00+00:00": 191.83999633789062,
      "2024-08-07T14:30:00+00:00": 196.0399932861328,
      "2024-08-07T15:30:00+00:00": 201.6699981689453,
      "2024-08-07T16:30:00+00:00": 203.0399932861328,
      "2024-08-07T17:30:00+00:00": 200.0,
      "2024-08-07T18:30:00+00:00": 199.25,
      "2024-08-07T19:30:00+00:00": 200.00999450683594
    },
    "sentiment": 0.8891208171844482
  },
  {
    "title": "Charles River reports Q2 EPS $2.80, consensus $2.39",
    "published": 1723012260,
    "day_prices": {
      "2024-08-07T13:30:00+00:00": 191.83999633789062,
      "2024-08-07T14:30:00+00:00": 196.0399932861328,
      "2024-08-07T15:30:00+00:00": 201.6699981689453,
      "2024-08-07T16:30:00+00:00": 203.0399932861328,
      "2024-08-07T17:30:00+00:00": 200.0,
      "2024-08-07T18:30:00+00:00": 199.25,
      "2024-08-07T19:30:00+00:00": 200.00999450683594
    },
    "sentiment": 0.41774988174438477
  },
  {
    "title": "Charles River price target lowered by $40 at Goldman Sachs, here's why",
    "published": 1723006440,
    "day_prices": {
      "2024-08-07T13:30:00+00:00": 191.83999633789062,
      "2024-08-07T14:30:00+00:00": 196.0399932861328,
      "2024-08-07T15:30:00+00:00": 201.6699981689453,
      "2024-08-07T16:30:00+00:00": 203.0399932861328,
      "2024-08-07T17:30:00+00:00": 200.0,
      "2024-08-07T18:30:00+00:00": 199.25,
      "2024-08-07T19:30:00+00:00": 200.00999450683594
    },
    "sentiment": 0.8413518071174622
  },
  {
    "title": "Charles River Laboratories Q2 2024 Earnings Preview",
    "published": 1722942780,
    "day_prices": {
      "2024-08-06T13:30:00+00:00": 227.57000732421875,
      "2024-08-06T14:30:00+00:00": 232.8300018310547,
      "2024-08-06T15:30:00+00:00": 231.1300048828125,
      "2024-08-06T16:30:00+00:00": 231.90499877929688,
      "2024-08-06T17:30:00+00:00": 231.61500549316406,
      "2024-08-06T18:30:00+00:00": 233.32000732421875,
      "2024-08-06T19:30:00+00:00": 230.6199951171875
    },
    "sentiment": 0.8055324554443359
  },
  {
    "title": "Carel Industries: Hold Rating Maintained Amidst Weak Sales and Uncertain Outlook",
    "published": 1722835080,
    "day_prices": {
      "2024-08-05T13:30:00+00:00": 225.25999450683594,
      "2024-08-05T14:30:00+00:00": 224.0,
      "2024-08-05T15:30:00+00:00": 227.0399932861328,
      "2024-08-05T16:30:00+00:00": 230.0500030517578,
      "2024-08-05T17:30:00+00:00": 227.47000122070312,
      "2024-08-05T18:30:00+00:00": 228.14999389648438,
      "2024-08-05T19:30:00+00:00": 227.0399932861328
    },
    "sentiment": 0.96939617395401
  },
  {
    "title": "Ariel Investments Appreciation Fund Q2 2024 Commentary",
    "published": 1722593400,
    "day_prices": {
      "2024-08-02T13:30:00+00:00": 236.8800048828125,
      "2024-08-02T14:30:00+00:00": 228.92999267578125,
      "2024-08-02T15:30:00+00:00": 230.72999572753906,
      "2024-08-02T16:30:00+00:00": 233.33999633789062,
      "2024-08-02T17:30:00+00:00": 232.82000732421875,
      "2024-08-02T18:30:00+00:00": 232.64999389648438,
      "2024-08-02T19:30:00+00:00": 234.97000122070312
    },
    "sentiment": 0.9173048734664917
  },
  {
    "title": "Ariel Investments Small/Mid Cap Value Q2 2024 Commentary",
    "published": 1722528000,
    "day_prices": {
      "2024-08-01T13:30:00+00:00": 244.60000610351562,
      "2024-08-01T14:30:00+00:00": 248.0800018310547,
      "2024-08-01T15:30:00+00:00": 243.3800048828125,
      "2024-08-01T16:30:00+00:00": 243.25,
      "2024-08-01T17:30:00+00:00": 243.39999389648438,
      "2024-08-01T18:30:00+00:00": 241.11810302734375,
      "2024-08-01T19:30:00+00:00": 241.6300048828125
    },
    "sentiment": 0.926652193069458
  }
]